Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Voice. 2014 May 28;28(5):652.e1–652.e20. doi: 10.1016/j.jvoice.2014.01.007

Table 5.

Investigations of systemic hydration induced voice changes in vivo employing pharmaceuticals

Ref Patient Hydration Inducement Hydration Measures Hydration Status Vocal Function Measures Main Results Conclusions
Roh et al. (2006)

(52)
20M
21–24 yr healthy
Method
Avoid caffeine, alcohol, high sodium food, drugs, dehydrating substances, excessive eating or drinking of water, strenuous voice use
  1. Xerostomia intramuscular injection 0.3mg (1.5ml) glycopyrrolate

  2. Control intramuscular injection 1.5ml saline



Timing
Timing for general avoidance not specifically stated.
Baseline, injections, post measure +3hrs
Method
Saliva volume by modified swab

Pt perception dry mouth (VAS)

Timing
Before & every 30mins for 3hrs post injection
Pre
Not measured

Post
Not measured
Measures
Acoustic
Fo, jitter, shimmer NHR, voice range profiles
Aerophone II max phonation time, average airflow, subglottal pressure
PTP
PPE - VAS post reading 20mins
Lx imaging VAS vibratory closure pattern, supraglottic activity, presence of mucus, color, mucosal wave, amp & symmetry

Timing
Pre ✓ Post ✓
Saliva flow rates ↓ ~50% post glycopyrrolate injection post 30–60mins, lowest 90–120mins post injection

Sig. ↑ dry mouth 30mins post highest level 120mins.

↑ PPE & PTP both groups post 3hrs, sig higher in treatment group.

Voice range profile sig. ↓ pitch & loudness in treatment group

No sig. change
Max phonation time, average airflow, videostroboscopy ratings
Glycopyrrolate may induce decreases in mucosal wetness of VFs as well as oral mucosa.

Salivary hypofunction may be closely related to vocal changes

A change in vocal function should be considered for irradiated patients - current data is similar to previous investigation in head & neck cancer patients
Akhtar et al. (1999)

(53)
8M
4F
27–55yr healthy
Method
250mg pure caffeine (5x Proplus tablets)

Timing
Post baseline measures
Method
Caffeine (mg/l) blood

Timing
Pre & 1hr post ingestion
Pre
Not measured

Post
Not measured
Measures
Laryngograph Irregularity of Fo

Free speech
Reading passage ‘Happy Birthday’

Timing
Pre ✓ Post ✓
Sig. effects btw patient, not within subjects (pre & post) in all 3 conditions

Caffeine mg/l varied between patients

Reading - substantial Fo variation in each task across patient prior to caffeine ingestion.
Considerable individual variability in response to caffeine ingestion

Mean percentage of irregularity increased over time suggesting an effect on the VFs caused by caffeine ingestion
Erickson-Levendoski & Sivasankar (2011)

(54)
8 M
8 F
18–27 yr

8 prior vocal training
Method
  1. Caffeine

    2x coffees (~480mg)

  2. Control - 2x decaf coffee (~24mg)



70% humidity

Timing
2 sessions at same time on 2 consecutive days
2nd coffee 2.3–3hrs post initial (left lab in between)
Method
Not measured

Timing
Not measured
Pre
Not measured

Post
Not measured
Measures
PTP 10 80
PPE - VAS - ‘Happy Birthday’ 50% pitch range

Measures taken post 35min & 70min vocal loading task

Timing
Pre ✓ Post ✓
No sig. effects of caffeine on PTP or PPE

Ingestion of caffeine did not worsen the effects of vocal loading on PTP or PPE

Vocal loading sig. ↑ PTP but not PPE
A high dose of caffeine does not adversely affect PTP or PPE measures
Ahmed et al. (2012)

(58)
25 adults healthy Method
  1. Caffeinated coffee ~400mg +routine water

  2. De-caffeinated coffee ~ 4–8mg +routine water

  3. Water only - ≤2l/day



Additional carbonated drinks if same caffeine category but not permitted in water group
No alcohol for any group
Timing
Ingestion of fluid for 2 days
Method
Drink diary

Timing
48h between measures
Pre
Not measured

Post
Not measured
Measures
Perceptual rating
GRBAS

Acoustics
Fo, jitter, shimmer

Timing
Pre ✓ Post ✓
No statistical diff. in any measure of voice quality between groups pre- or post- intervention Caffeinated coffee does not have a sig. detrimental effect on voice quality
Tanaka et al. (2001)

(55)
4 M
26–35 yr healthy
Method
Intravenous injection of atropine sulfate 0.5mg

Timing
10mins prior to testing
Method
Not measured

Timing
Not measured
Pre
Not measured

Post
Not measured
Measures
Change in frequency per unit change in transglottal pressure (dF/dP)
Timing
Pre ✓ Post ✓
Pt perceived dry throat post atropine
No perceived hoarseness

dF/dP ↓ at lower Fo but not higher Fo
Relationship between dF/DP & Fo reflects length-versus-depth adjustments for Fo control